LL-37 is the only known human cathelicidin-derived antimicrobial peptide, encoded by the CAMP gene. It has attracted growing interest in research focused on innate immunity, wound healing, and inflammation regulation.

Studies have shown that LL-37 exhibits broad-spectrum antimicrobial activity against bacteria, viruses, and fungi by disrupting microbial membranes. It also functions as an immunomodulatory peptide, influencing chemotaxis, cytokine release, and angiogenesis. It may also play a role in biofilm disruption, tissue repair, and modulation of inflammatory responses in chronic conditions.

Key Research Areas:

  • Broad-spectrum antimicrobial activity and membrane disruption

  • Immunomodulation and chemotaxis regulation

  • Wound healing and angiogenesis promotion

  • Biofilm eradication and infection control

  • Chronic inflammation and autoimmune research

Anti-inflammatoryFor research use onlyImmune healthWound healing